Literature DB >> 7789058

Characterization of systemic lupus erythematosus in patients in U.A.E.

H M al-Attia1, S George.   

Abstract

Twenty-eight SLE patients (Arabs and Asians) in the UAE were studied in this report. The F:M ratio was markedly high; 27:1 in the group as a whole and 21:1 among Arabs. Local patients (Emirians) developed the disease at an earlier age compared to their expatriate Arab compatriots. Arthropathy occurred in 86% and nephropathy in 43% of cases. Next in frequency were leucopenia, mucocutaneous manifestations and serositis. Apart from lupus headache, the other neuro-psychiatric LE were uncommon or not encountered. Anti-cardiolipin syndrome, Sneddon's syndrome, shrunken lung syndrome, sicca complex, thyrotoxicosis and myasthenia gravis were also present in this small group of patients. Their presence reflects the marked heterogeneity displayed by the disease irrespective of the number of cases involved. An unusually high prevalence of anti ds (DNA) antibodies (92.5%) as compared to ANF (82.5%) was detected (P = NS). Anti-Sm antibody occurred in 30% of cases particularly in those patients with lymphadenopathy and fever. There was a relative paucity in the prevalence of anti RNP, Ro and La antibodies in this group. Differences with and similarities to previous reports concerning other populations are also presented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7789058     DOI: 10.1007/bf02214938

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Autoantibodies and the spectrum of Sjögren's syndrome.

Authors:  M Martinez-Lavin; J H Vaughan; E M Tan
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

2.  Systemic lupus erythematosus in northern India: a review of 329 cases.

Authors:  A N Malaviya; R R Singh; A Kumar; A De; A Kumar; S Aradhye
Journal:  J Assoc Physicians India       Date:  1988-08

3.  Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus.

Authors:  R Yokohari; T Tsunematsu
Journal:  Arthritis Rheum       Date:  1985-06

4.  Rheumatoid arthritis in a population sample in the Gulf: clinical observations.

Authors:  H M al Attia; O B Gatee; S George; M M Masri
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

5.  Autoantibodies in lupus and its variants: experience in 1000 patients.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11

6.  High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent.

Authors:  R A Kaslow
Journal:  Arthritis Rheum       Date:  1982-04

7.  Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus.

Authors:  R M Blaese; J Grayson; A D Steinberg
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

8.  Clinical features of systemic lupus erythematosus: differences related to race and age of onset.

Authors:  S P Ballou; M A Khan; I Kushner
Journal:  Arthritis Rheum       Date:  1982-01

9.  Systemic lupus erythematosus in Zimbabwe.

Authors:  H G Taylor; C M Stein
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

10.  Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic lupus erythematosus.

Authors:  A Weinstein; B Bordwell; B Stone; C Tibbetts; N F Rothfield
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

View more
  1 in total

1.  Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program.

Authors:  Michelle Housey; Peter DeGuire; Sarah Lyon-Callo; Lu Wang; Wendy Marder; W Joseph McCune; Charles G Helmick; Caroline Gordon; J Patricia Dhar; James Leisen; Emily C Somers
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.